Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

XENETIC BIOSCIENCES, INC. (XBIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

XENETIC BIOSCIENCES, INC. (XBIO), most recent 12 months reported: revenue $3.26M, net loss $2.48M. Latest balance sheet on file: liquid cash $7.88M. From SEC filings. Others in Pharmaceutical Preparations: ProPhase Labs, Inc. · MARKER THERAPEUTICS, INC. · NRX Pharmaceuticals, Inc. · TherapeuticsMD, Inc. · Polomar Health Services, Inc. · UPSTREAM BIO, INC. · Connect Biopharma Holdings Limited · BIO ESSENCE CORP.

Stock screener

Watchlist